image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 6.83
-7.11 %
$ 108 M
Market Cap
-0.67
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AMWL stock under the worst case scenario is HIDDEN Compared to the current market price of 6.83 USD, American Well Corporation is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AMWL stock under the base case scenario is HIDDEN Compared to the current market price of 6.83 USD, American Well Corporation is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AMWL stock under the best case scenario is HIDDEN Compared to the current market price of 6.83 USD, American Well Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart AMWL

image
$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
254 M REVENUE
-1.81%
-218 M OPERATING INCOME
68.57%
-213 M NET INCOME
68.51%
-127 M OPERATING CASH FLOW
14.16%
-18.7 M INVESTING CASH FLOW
2.69%
1.38 M FINANCING CASH FLOW
-35.68%
66.8 M REVENUE
-5.88%
-30.4 M OPERATING INCOME
28.87%
-18.4 M NET INCOME
56.97%
-25.1 M OPERATING CASH FLOW
-86.89%
19.4 M INVESTING CASH FLOW
569.40%
543 K FINANCING CASH FLOW
27250.00%
Balance Sheet American Well Corporation
image
Current Assets 317 M
Cash & Short-Term Investments 228 M
Receivables 71.9 M
Other Current Assets 16.8 M
Non-Current Assets 119 M
Long-Term Investments 1.5 M
PP&E 7.58 M
Other Non-Current Assets 110 M
52.37 %16.49 %3.85 %25.21 %Total Assets$436.0m
Current Liabilities 111 M
Accounts Payable 5.02 M
Short-Term Debt 3.69 M
Other Current Liabilities 103 M
Non-Current Liabilities 8.46 M
Long-Term Debt 0
Other Non-Current Liabilities 8.46 M
4.19 %3.08 %85.66 %7.07 %Total Liabilities$119.7m
EFFICIENCY
Earnings Waterfall American Well Corporation
image
Revenue 254 M
Cost Of Revenue 155 M
Gross Profit 99 M
Operating Expenses 316 M
Operating Income -218 M
Other Expenses -4.9 M
Net Income -213 M
300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)254m(155m)99m(316m)(218m)5m(213m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
38.90% GROSS MARGIN
38.90%
-85.52% OPERATING MARGIN
-85.52%
-81.83% NET MARGIN
-81.83%
-68.29% ROE
-68.29%
-47.74% ROA
-47.74%
-67.12% ROIC
-67.12%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis American Well Corporation
image
00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)20192019202020202021202120222022202320232024202420252025
Net Income -213 M
Depreciation & Amortization 33 M
Capital Expenditures -15.2 M
Stock-Based Compensation 0
Change in Working Capital 0
Others 85.5 M
Free Cash Flow -143 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets American Well Corporation
image
Wall Street analysts predict an average 1-year price target for AMWL of $7.2 , with forecasts ranging from a low of $5 to a high of $10 .
AMWL Lowest Price Target Wall Street Target
5 USD -26.79%
AMWL Average Price Target Wall Street Target
7.2 USD 5.42%
AMWL Highest Price Target Wall Street Target
10 USD 46.41%
Price
Max Price Target
Min Price Target
Average Price Target
13131212111110109988776655Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership American Well Corporation
image
Sold
0-3 MONTHS
53.9 K USD 2
3-6 MONTHS
177 K USD 5
6-9 MONTHS
622 K USD 7
9-12 MONTHS
197 K USD 7
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Amwell makes grant to new employee under inducement plan BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. globenewswire.com - 1 week ago
All You Need to Know About American Well (AMWL) Rating Upgrade to Buy American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). zacks.com - 1 week ago
Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect? The consensus price target hints at a 46.5% upside potential for American Well (AMWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com - 1 week ago
Is American Well (AMWL) Outperforming Other Medical Stocks This Year? Here is how American Well Corporation (AMWL) and Claritev Corporation (CTEV) have performed compared to their sector so far this year. zacks.com - 1 week ago
American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for American Well (AMWL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 2 weeks ago
American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript American Well Corporation (NYSE:AMWL ) Q1 2025 Results Conference Call May 1, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Charles Rhyee - TD Cowen Jailendra Singh - Truist Stan Berenshteyn - Wells Fargo Securities LLC Eric Percher - Nephron David Larsen - BTIG Matt Shea - Needham Operator Good day, and thank you for standing by. Welcome to Amwell's First Quarter 2025 Earnings Conference Call. seekingalpha.com - 2 weeks ago
American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates American Well Corporation (AMWL) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $3.09. This compares to loss of $5 per share a year ago. zacks.com - 2 weeks ago
Amwell® Announces Results for First Quarter 2025 BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. globenewswire.com - 2 weeks ago
Amwell® to participate in upcoming investor conferences BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually.  On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City. globenewswire.com - 3 weeks ago
Amwell® to report first quarter 2025 operating results BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. globenewswire.com - 1 month ago
Amwell makes inducement grant BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky's employment as Amwell's chief product and technology officer. globenewswire.com - 2 months ago
Amwell announces innovation leader as chief product and technology officer BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations. globenewswire.com - 2 months ago
8. Profile Summary

American Well Corporation AMWL

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 108 M
Dividend Yield 0.00%
Description American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Contact 75 State Street, Boston, MA, 02109 https://amwell.com
IPO Date Sept. 17, 2020
Employees 877
Officers Dr. Ido Schoenberg M.D. Chairman & Chief Executive Officer Mr. Paul Francis McNeice Vice President of Accounting Mr. Dan Zamansky Chief Product & Technology Officer Ms. Amber Howe Chief People Officer Mr. Mark J. Hirschhorn CPA Executive Vice President, Chief Operating Officer & Chief Financial Officer Ms. Phyllis I. Gotlib President of Amwell International Ms. Sue Dooley Head of Investor Relations Anna Nesterova Head of Legal Dr. Cynthia Horner FAAFP, M.D. Chief Medical Officer & President of Amwell Medical Group Dr. Roy Schoenberg M.D., M.P.H. Executive Vice Chairman